Comparative Study Between Conventional Radiofrequency Ablation vs Chemical Neurolysis of Ganglion Impar for Treatment of Chronic Non Cancer Related Coccydynia
Active, not recruitingNot applicableNCT07247565
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Aim: compare effectiveness (satisfaction) and duration of pain relief between patients who perform the conventional thermal radiofrequency on the ganglion impar vs patients who perform the chemical neurolysis with alcohol in patients with non cancer coccydynia patients with non cancer coccydynia not responding to medical treatment will be divided into 2 groups before intervention , control group will receive conventional radiofrequency ablation of ganglion impar , while the study group will receive alcohol neurolysis
Study details
- Official title
- Comparative Study Between Conventional Radiofrequency Ablation vs Chemical Neurolysis of Ganglion Impar for Treatment of Chronic Non Cancer Related Coccydynia
- Conditions
- Interventions
- Procedure: Radiofrequency ablation alone
- Procedure: Alcohol injection
- Sponsor
- Ain Shams University
- Start date
- 2025-03-01
- Primary completion
- 2025-11
- Sex
- All
- Age range
- from 20 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * non cancer coccydynia 1. Both genders 2. Age between 20-70 years. 3. ASA 1,2 \& 3 physical status 4. xray coccyx lateral position showing normal joints and bones with no fractures Exclusion Criteria: * Neurological disorders. (previous central and peripheral CNS affection). * coagulopathy INR \> 1.8 or platelets \< 50,000. * Infection at or near the injection site. * Presence of pacemaker or defibrillator. * known allergy to used medications. * patients with previous history of Radiotherapy, chemotherapy or metastasis * pregnant patients. * patients with rheumatological disorders (rheumatoid arthritis, diffuse idiopathic skeletal hyerostosis, psoriatic arthritis) * age \<20 or \>70 * Xray coccyx showing fractures or abnormalities
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07247565